Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma

Camille Péneau, Sandrine Imbeaud, Tiziana La Bella, +9

Gut

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response

Stefano Caruso, Anna-Line Calatayud, Jill Pilet, +17

Gastroenterology

In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis

Francesca Fornari, Daniela Pollutri, Clarissa Patrizi, +16

Clinical Cancer Research

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

Quentin Bayard, Léa Meunier, Camille Péneau, +19

Nature Communications

Adeno-associated virus in the liver: natural history and consequences in tumour development

Tiziana La Bella, Sandrine Imbeaud, Camille Péneau, +18

Gut

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity <i>In Vitro</i>

Sandra Rebouissou, Tiziana La Bella, Samia Rekik, +12

Clinical Cancer Research

A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III

Antoine Gardin, Jérémy Rouillon, Valle Montalvo-Romeral, +19

Journal of Clinical Investigation